David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Galderma for sale – why we need the right buyer

Written by on September 27, 2018 in Galderma with 1 Comment
Galderma for sale – why we need the right buyer

A for-sale sign is hanging outside the Galderma shop, shall we make them an offer? The rosacea behemoth that is Galderma could be about to change hands, read on to find out this sale could mean for rosacea sufferers and why we all have an interest in the new owner. Galderma was created in 1981 […]

Continue Reading

BioPharmX developing topical Minocycline Gel 1%

Written by on September 13, 2018 in Antibiotics, clinical trials, minocycline with 2 Comments
BioPharmX developing topical Minocycline Gel 1%

A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability and promising efficacy in rosacea” and also showcases “the value of our anhydrous hydrophilic topical delivery system.” The trial will compare the […]

Continue Reading

Generic Oracea – sadly just not going to happen

Generic Oracea – sadly just not going to happen

A recent ruling from a Delaware Federal judge has confirmed that Galderma’s patent protection covering Oracea is secure, and confirming that generic Oracea is just not going to happen. This most recent ruling found that Amneal Pharmaceuticals’s attempt to create a generic version of the once-daily low dose doxycycline treatment infringes 5 of Galderma’s US […]

Continue Reading

UK Health Regulator warns about Mirvaso and cardiovascular effects

Written by on August 8, 2018 in Mirvaso Gel (Brimonidine 0.33%) with 0 Comments
UK Health Regulator warns about Mirvaso and cardiovascular effects

  The regulator of healthcare products in the UK has issued a Drug Safety Update related to the topical treatment for the red face of rosacea – Mirvaso. This update was issued in June 2017 and seems to have gone largely unnoticed by rosacea sufferers online. Here is why it has been issued, and what […]

Continue Reading

Leo Pharma is the new owner of Finacea

Leo Pharma is the new owner of Finacea

News today that Bayer HealthCare is selling its prescription dermatology business to the unlisted Danish company Leo Pharma. Leo Pharma now becomes an interesting company for rosacea sufferers given the prevalence and efficacy of both Finacea and Finacea Foam. The future of these products and any related funded research now rests with Leo Pharma. LEO […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.